Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling

Frontiers in Physiology

Volumn 5 JUN, Issue , 2014, Pages

  Reichrath, Jörg ^a   Reichrath, Sandra ^a   Heyne, Kristina ^a   Vogt, Thomas ^a   Roemer, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cancer; MDM2; p53; Vitamin D; Vitamin D receptor

Indexed keywords

ALPHA INTERMEDIN; CALCITRIOL; CORTICOTROPIN; PROTEIN MDM2; PROTEIN P53; RETINOID X RECEPTOR; THYMINE; VITAMIN D RECEPTOR;

CANCER INHIBITION; CELL SURVIVAL; DNA DAMAGE; ENZYME ACTIVITY; ENZYME REGULATION; GENE TARGETING; HUMAN; MDM2 GENE; MOLECULAR INTERACTION; NON MELANOMA SKIN CANCER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN CELL; SKIN PIGMENTATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION; VDR GENE;

EID: 84904354678     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00166     Document Type: Review

References (101)

1. Agar, N. S., Halliday, G. M., Barnetson, R. S., Ananthaswamy, H. N., Wheeler, M., and Jones, A. M. (2004). The basal layer in human squamous tumours harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 4954-4959. doi: 10.1073/pnas.0401141101
2. Applegate, L. A., Ley, R. D., Alcalay, J., and Kripke, M. L. (1989). Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J. Exp. Med. 170, 1117-1131. doi: 10.1084/jem.170.4.1117
3. Applegate, L. A., Scaletta, C., Panizzon, R., Niggli, H., and Frenk, E. (1999). In vivo induction of pyrimidine dimers in human skin by UVA radiation: initiation of cell damage and/or intercellular communication? Int. J. Mol. Med. 3, 467-472. doi: 10.3892/ijmm.3.5.467
4. Araki, S., Eitel, J. A., Batuello, C. N., Bijangi-Vishehsaraei, K., Xie, X. J., Danielpour, D., et al. (2010). TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J. Clin. Invest. 120, 290-302. doi: 10.1172/JCI39194
5. Ashcroft, M., Taya, Y., and Vousden, K. H. (2000). Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 20, 3224-3233. doi: 10.1128/MCB.20.9.3224-3233.2000
6. Barak, Y., Gottlieb, E., Juven-Gershon, T., and Oren, M. (1994). Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 8, 1739-1749. doi: 10.1101/gad.8.15.1739
7. Besaratinia, A., Kim, S. I., and Pfeifer, G. P. (2008). Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J. 22, 2379-2392. doi: 10.1096/fj.07-105437
8. Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., et al. (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumour suppressor pathway and accelerates tumour formation in humans. Cell 119, 591-602. doi: 10.1016/j.cell.2004.11.022
9. Brandt, T., Petrovich, M., Joerger, A. C., and Veprintsev, D. B. (2009). Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics 10:628. doi: 10.1186/1471-2164-10-628
10. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., et al. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 88, 10124-10128. doi: 10.1073/pnas.88.22.10124
11. Bruch-Gerharz, D., Ruzicka, T., and Kolb-Bachofen, V. (1998). Nitric oxide in human skin: current status and future prospects. J. Invest. Dermatol. 110, 1-7. doi: 10.1046/j.1523-1747.1998.00084.x
12. Cals-Grierson, M. M., and Ormerod, A. D. (2004). Nitric oxide function in the skin. Nitric Oxide 10, 179-193. doi: 10.1016/j.niox.2004.04.005
13. Candi, E., Dinsdale, D., Rufini, A., Salomoni, P., Knight, R. A., Mueller, M., et al. (2007). TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 6, 274-285. doi: 10.4161/cc.6.3.3797
14. Chen, H., Hays, E., Liboon, J., Neely, C., Kolman, K., and Chandar, N. (2011). Osteocalcin gene expression is regulated by wild-type p53. Calcif. Tissue Int. 89, 411-418. doi: 10.1007/s00223-011-9533-x
15. Chen, H., Reed, G., Guardia, J., Lakhan, S., Couture, O., Hays, E., et al. (2013). Vitamin D directly regulates Mdm2 gene expression in osteoblasts. Biochem. Biophys. Res. Commun. 430, 370-374. doi: 10.1016/j.bbrc.2012.11.003
16. Chen, J., Marechal, V., and Levine, A. J. (1993). Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107-4114.
17. Chen, K., Aenlle, K. K., Curtis, K. M., Roos, B. A., and Howard, G. A. (2012). Hepatocyte growth factor (HGF) and 1,25-dihydroxyvitamin D together stimulate human bone marrow-derived stem cells toward the osteogenic phenotype by HGF-induced up-regulation of VDR. Bone 51, 69-77. doi: 10.1016/j.bone.2012.04.002
18. Choi, J., and Donehower, L. A. (1999). p53 in embryonic development: maintaining a fine balance. Cell. Mol. Life Sci. 55, 38-47. doi: 10.1007/s000180050268
19. Cooke, M. S., Podmore, I. D., Mistry, N., Evans, M. D., Herbert, K. E., Griffiths, H. R. et al. (2003). Immunochemical detection of UV-induced DNA damage and repair. J Immunol Methods. 280, 125-133. doi: 10.1016/S0022-1759(03)00269-2
20. Courdavault, S., Baudouin, C., Charveron, M., Favier, A., Cadet, J., and Douki, T. (2004a). Larger yield of cyclobutane dimers than 8-oxo-7,8-dihydroguanine in the DNA of UVA-irradiated human skin cells. Mutat. Res. 556, 135-142. doi: 10.1016/j.mrfmmm.2004.07.011
21. Courdavault, S., Baudouin, C., Sauvaigo, S., Mouret, S., Candéias, S., Charveron, M., et al. (2004b). Unrepaired cyclobutane pyrimidine dimers do not prevent proliferation of UV-B-irradiated cultured human fibroblasts. Photochem. Photobiol. 79, 145-151. doi: 10.1562/0031-8655(2004)079<0145:UCPDDN>2.0.CO;2
22. Danilova, N., Sakamoto, K. M., and Lin, S. (2008). p53 family in development. Mech. Dev. 125, 919-931. doi: 10.1016/j.mod.2008.09.003
23. De Laurenzi, V., Raschella, G., Barcaroli, D., Annicchiarico-Petruzzelli, M., Ranalli M, Catani, M. V., et al. (2000). Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J. Biol. Chem. 275, 15226-15231. doi: 10.1074/jbc.275.20.15226
24. Deliconstantinos, G., Villiotou, V., and Stravrides, J. C. (1995). Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production. Br. J. Pharmacol. 114, 1257-1265. doi: 10.1111/j.1476-5381.1995.tb13341.x
25. Douki, T., Court, M., Sauvaigo, S., Odin, F., and Cadet, J. (2000). Formation of the main UV-induced thymine dimeric lesions within isolated and cellular DNA as measured by high performance liquid chromatography-tandem mass spectrometry. J. Biol. Chem. 275, 11678-11685. doi: 10.1074/jbc.275.16.11678
26. Dumble, M., Moore, L., Chambers, S. M., Geiger, H., Van Zant, G., Goodell, M. A., et al. (2007). The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 109, 1736-1742. doi: 10.1182/blood-2006-03-010413
27. Feng, Z., Hu, W., Rajagopal, G., and Levine, A. J. (2008). The tumour suppressor p53: cancer and aging. Cell Cycle 7, 842-847. doi: 10.4161/cc.7.7.5657
28. Flores, E. R. (2007). The roles of p63 in cancer. Cell Cycle 6, 300-304. doi: 10.4161/cc.6.3.3793
29. Ganguli, G., and Wasylyk, B. (2003). p53-independent functions of MDM2. Mol. Cancer Res. 1, 1027-1035.
30. Gatza, C., Moore, L., Dumble, M., and Donehower, L. A. (2007). Tumour suppressor dosage regulates stem cell dynamics during aging. Cell Cycle 6, 52-55. doi: 10.4161/cc.6.1.3667
31. Gil-Perotin, S., Marin-Husstege, M., Li, J., Soriano-Navarro, M., Zindy, F., Roussel, M. F., et al. (2006). Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumours. J. Neurosci. 26, 1107-1116. doi: 10.1523/JNEUROSCI.3970-05.2006
32. Gressner, O., Schilling, T., Lorenz, K., Schulze Schleithoff, E., Koch, A., Schulze-Bergkamen, H., et al. (2005). TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J. 24, 2458-2471. doi: 10.1038/sj.emboj.7600708
33. Gu, W., and Roeder, R. G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606. doi: 10.1016/S0092-8674(00)80521-8
34. Gupta, R., Dixon, K. M., Deo, S. S., Holliday, C. J., Slater, M., Halliday, G. M., et al. (2007). Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J. Invest. Dermatol. 27, 707-715. doi: 10.1038/sj.jid.5700597
35. Hart, R. W., Setlow, R. B., and Woodhead, A. D. (1977). Evidence that pyrimidine dimers in DNA can give rise to tumours. Proc. Natl. Acad. Sci. U.S.A. 74, 5574-5578. doi: 10.1073/pnas.74.12.5574
36. Haussler, M. R., Whitfield, G. K., Kaneko, I., Haussler, C. A., Hsieh, D., Hsieh, J. C., et al. (2012). Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92, 77-98. doi: 10.1007/s00223-012-9619-0
37. Holick, M. F. (2007). Vitamin D deficiency. N. Engl. J. Med. 357, 266-281. doi: 10.1056/NEJMra070553
38. Hollstein, M., and Hainaut, P. (2010). Massively regulated genes: the example of TP53. J. Pathol. 220, 164-173. doi: 10.1002/path.2637
39. Hu, W., Feng, Z., Atwal, G. S., and Levine, A. J. (2008). p53: a new player in reproduction. Cell Cycle 7, 848-852. doi: 10.4161/cc.7.7.5658
40. Jacobs, W. B., Govoni, G., Ho, D., Atwal, J. K., Barnabe-Heider, F., Keyes, W. M., et al. (2005). p63 is an essential proapoptotic protein during neural development. Neuron. 48, 743-756. doi: 10.1016/j.neuron.2005.10.027
41. Jacobs, W. B., Walsh, G. S., and Miller, F. D. (2004). Neuronal survival and p73/p63/p53: a family affair. Neuroscientist 10, 443-455. doi: 10.1177/1073858404263456
42. Jiang, W., Ananthaswamy, H. N., Muller, H. K., and Kripke, M. L. (1999). p53 protects against skin cancer induction by UV-B radiation. Oncogene 18, 4247-4253. doi: 10.1038/sj.onc.1202789
43. Kommagani, R., Payal, V., and Kadakia, M. P. (2007). Differential regulation of vitamin D receptor (VDR) by the p53 Family: p73-dependent induction of VDR upon DNA damage. J. Biol. Chem. 282, 29847-29854. doi: 10.1074/jbc.M703641200
44. Kommagani, R., Whitlatch, A., Leonard, M. K., and Kadakia, M. P. (2010). p73 is essential for vitamin D-mediated osteoblastic differentiation. Cell Death Differ. 17, 398-407. doi: 10.1038/cdd.2009.135
45. Koster, M. I., Dai, D., and Roop, D. R. (2007). Conflicting roles for p63 in skin development and carcinogenesis. Cell Cycle 6, 269-273. doi: 10.4161/cc.6.3.3792
46. Kripke, M. L., Cox, P. A., Alas, L. G., and Yarosh, D. B. (1992). Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc. Natl. Acad. Sci. U.S.A. 89, 7516-7520. doi: 10.1073/pnas.89.16.7516
47. Kruse, J. P., and Gu, W. (2009). Modes of p53 regulation. Cell 137, 609-622. doi: 10.1016/j.cell.2009.04.050
48. Lee, H., and Kimelman, D. (2002). A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. Dev. Cell. 2, 607-616. doi: 10.1016/S1534-5807(02)00166-1
49. Lehmann, B., Querings, K., and Reichrath, J. (2004). Vitamin D and skin: new aspects for dermatology. Exp. Dermatol. 13, 11-15. doi: 10.1111/j.1600-0625.2004.00257.x
50. Lengner, C. J., Steinman, H. A., Gagnon, J., Smith, T. W., Henderson, J. E., Kream, B. E., et al. (2006). Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J. Cell Biol. 172, 909-921. doi: 10.1083/jcb.200508130
51. Levine, A. J., and Oren, M. (2009). The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer. 9, 749-758. doi: 10.1038/nrc2723
52. Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., et al. (2005). p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7, 165-171. doi: 10.1038/ncb1211
53. Lin, Y. L., Sengupta, S., Gurdziel, K., Bell, G. W., Jacks, T., and Flores, E. R. (2009). p63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet. 5:e1000680. doi: 10.1371/journal.pgen.1000680
54. Marine, J. C., Francoz, S., Maetens, M., Wahl, G., Toledo, F., and Lozano, G. (2006). Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 13, 927-934. doi: 10.1038/sj.cdd.4401912
55. Maruyama, R., Aoki, F., Toyota, M., Sasaki, Y., Akashi, H., Mita, H., et al. (2006). Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res. 66, 4574-4583. doi: 10.1158/0008-5472.CAN-05-2562
56. Mason, R. S., and Reichrath, J. (2013). Sunlight vitamin D and skin cancer. Anticancer Agents Med. Chem. 13, 83-97. doi: 10.2174/187152013804487272
57. Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., et al. (2006). p53 regulates mitochondrial respiration. Science 312, 1650-1653. doi: 10.1126/science.1126863
58. McKeon, F., and Melino, G. (2007). Fog of war: the emerging p53 family. Cell Cycle 6, 229-232. doi: 10.4161/cc.6.3.3876
59. Mikkola, M. L. (2007). p63 in skin appendage development. Cell Cycle 6, 285-290. doi: 10.4161/cc.6.3.3798
60. Miller, F. D., and Kaplan, D. R. (2007). To die or not to die: neurons and p63. Cell Cycle 6, 312-317. doi: 10.4161/cc.6.3.3795
61. Mouret, S., Baudouin, C., Charveron, M., Favier, A., Cadet, J., and Douki, T. (2006). Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc. Natl. Acad. Sci. U.S.A. 103, 13765-13770. doi: 10.1073/pnas.0604213103
62. Mowbray, M., McLintock, S., Weerakoon, R., Lomatschinsky, N., Jones, S., Rossi, A. G., et al. (2009). Enzyme-independent NO stores in human skin: quantification and influence of UV radiation. J. Invest. Dermatol. 129, 834-842. doi: 10.1038/jid.2008.296
63. Murray-Zmijewski, F., Lane, D. P., and Bourdon, J. C. (2006). p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ. 13, 962-972. doi: 10.1038/sj.cdd.4401914
64. Nylander, K., Vojtesek, B., Nenutil, R., Lindgren, B., Roos, G., Zhanxiang, W., et al. (2002). Differential expression of p63 isoforms in normal tissues and neoplastic cells. J. Pathol. 198, 417-427. doi: 10.1002/path.1231
65. Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A., Kim, M. S., et al. (2005). Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell. Biol. 25, 6077-6089. doi: 10.1128/MCB.25.14.6077-6089.2005
66. Park, B. J., Lee, S. J., Kim, J. I., Lee, S. J., Lee, C. H., Chang, S. G., et al. (2000). Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res. 60, 3370-3374.
67. Pattison, D. I., and Davies, M. J. (2006). Actions of ultraviolet light on cellular structures. EXS 96, 131-157. doi: 10.1007/3-7643-7378-4_6
68. Paunel, A., Dejam, A., Thelen, S., Kirsch, M., Horstjann, M., Gharini, P., et al. (2005). UVA induces immediate and enzyme-independent nitric oxide formation in healthy human skin leading to NO-specific signalling. J. Invest. Dermatol. 125:A3.
69. Pellegrini, G., Dellambra, E., Golisano, O., Martinelli, E., Fantozzi, I., Bondanza, S., et al. (2001). p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. U.S.A. 98, 3156-3161. doi: 10.1073/pnas.061032098
70. Perez, C. A., and Pietenpol, J. A. (2007). Transcriptional programs regulated by p63 in normal epithelium and tumours. Cell Cycle 6, 246-254. doi: 10.4161/cc.6.3.3801
71. Ravanat, J. L., Douki, T., and Cadet, J. (2001). Direct and indirect effects of UV radiation on DNA and its components. J. Photochem. Photobiol. B. 63, 88-102. doi: 10.1016/S1011-1344(01)00206-8
72. Reichrath, J., and Reichrath, S. (2012). Hope and challenge: the importance of ultraviolet (UV) radiation for cutaneous vitamin D synthesis and skin cancer. Scand. J. Clin. Lab. Invest. Suppl. 243, 112-119. doi: 10.3109/00365513.2012.682876
73. Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., et al. (2000). Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103, 321-330. doi: 10.1016/S0092-8674(00)00123-9
74. Riley, T., Sontag, E., Chen, P., and Levine, A. (2008). Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9, 402-412. doi: 10.1038/nrm2395
75. Rochette, P. J., Therrien, J., Drouin, R., Perdiz, D., Bastien, N., and Drobetsky, E. A., et al. (2003). UVA-induced cyclobutane pyrimidine dimers form predominantly at thymine-thymine dipyrimidines and correlate with the mutation spectrum in rodent cells. Nucleic Acids Res. 31, 2786-2794. doi: 10.1093/nar/gkg402
76. Roemer, K. (2012). Notch and the p53 clan of transcription factors. Adv. Exp. Med. Biol. 727, 223-240. doi: 10.1007/978-1-4614-0899-4_17
77. Saramaki, A., Banwell, C. M., Campbell, M. J., and Carlberg, C. (2006). Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 34, 543-554. doi: 10.1093/nar/gkj460
78. Sbisa, E., Catalano, D., Grillo, G., Licciulli, F., Turi, A., Liuni, S., et al. (2007). p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data. BMC Bioinformatics 8(Suppl. 1):S20. doi: 10.1186/1471-2105-8-S1-S20
79. Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Siegfried, Z., et al. (2010). Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell. 17, 273-285. doi: 10.1016/j.ccr.2009.11.025
80. Steinman, H. A., Burstein, E., Lengner, C., Gosselin, J., Pihan, G., Duckett, C. S., et al. (2004). An alternative splice form of Mdm2 induces p53-independent cell growth and tumourigenesis. J. Biol. Chem. 279, 4877-4886. doi: 10.1074/jbc.M305966200
81. Suh, E. K., Yang, A., Kettenbach, A., Bamberger, C., Michaelis, A. H., Zhu, Z., et al. (2006). p63 protects the female germ line during meiotic arrest. Nature 444, 624-628. doi: 10.1038/nature05337
82. Sutherland, B. M., Blackett, A. D., Feng, N. I., Freeman, S. E., Ogut, E. S., Gange, R. W., et al. (1985). Photoreactivation and other ultraviolet/visible light effects on DNA in human skin. Ann. N.Y. Acad. Sci. 453, 73-79. doi: 10.1111/j.1749-6632.1985.tb11799.x
83. Talos, F., Nemajerova, A., Flores, E. R., Petrenko, O., and Moll, U. M. (2007). p73 suppresses polyploidy and aneuploidy in the absence of functional p53. Mol. Cell. 27, 647-659. doi: 10.1016/j.molcel.2007.06.036
84. Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., and Asgari, M. M. (2012a). Vitamin D in cutaneous carcinogenesis: Part I. J. Am. Acad. Dermatol. 67, 803.e1-803.e12. doi: 10.1016/j.jaad.2012.05.044
85. Tang, J. Y., Fu, T., Lau, C., Oh, D. H., Bikle, D. D., and Asgari, M. M. (2012b). Vitamin D in cutaneous carcinogenesis: Part II. J. Am. Acad. Dermatol. 67, 817.e1-817.e11. doi: 10.1016/j.jaad.2012.07.022
86. Toledo, F., and Wahl, G. M. (2006). Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer. 6, 909-923. doi: 10.1038/nrc2012
87. Tomasini, R., Tsuchihara, K., Wilhelm, M., Fujitani, M., Rufini, A., Cheung, C. C., et al. (2008). TAp73 knockout shows genomic instability with infertility and tumour suppressor functions. Genes Dev. 22, 2677-2691. doi: 10.1101/gad.1695308
88. Truong, A. B., Kretz, M., Ridky, T. W., Kimmel, R., and Khavari, P. A. (2006). p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 20, 3185-3197. doi: 10.1101/gad.1463206
89. Varley, J. M. (2003). Germline TP53 mutations and Li-Fraumeni syndrome. Hum. Mutat. 21, 313-320. doi: 10.1002/humu.10185
90. Vousden, K. H., and Lane, D. P. (2007). p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283. doi: 10.1038/nrm2147
91. Vousden, K. H., and Prives, C. (2009). Blinded by the light: the growing complexity of p53. Cell. 137, 413-431. doi: 10.1016/j.cell.2009.04.037
92. Wallingford, J. B., Seufert, D. W., Virta, V. C., and Vize, P. D. (1997). p53 activity is essential for normal development in Xenopus. Curr. Biol. 7, 747-757. doi: 10.1016/S0960-9822(06)00333-2
93. Wang, S., and El-Deiry, W. S. (2006). p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints. Cancer Res. 66, 6982-6989. doi: 10.1158/0008-5472.CAN-06-0511
94. Wang, X., Taplick, J., Geva, N., and Oren, M. (2004). Inhibition of p53 degradation by Mdm2 acetylation. FEBS Lett. 561, 195-201. doi: 10.1016/S0014-5793(04)00168-1
95. Westfall, M. D., Mays, D. J., Sniezek, J. C., and Pietenpol, J. A. (2003). The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 23, 2264-2276. doi: 10.1128/MCB.23.7.2264-2276.2003
96. Wikonkal, N. M., and Brash, D. E. (1999). Ultraviolet radiation induced signature mutations in photocarcinogenesis. J. Invest. Dermatol. Symp. Proc. 4, 6-10. doi: 10.1038/sj.jidsp.5640173
97. Yamaguchi, Y., and Hearing, V. J. (2009). Physiological factors that regulate skin pigmentation. Biofactors 35, 193-199. doi: 10.1002/biof.29
98. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., et al. (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell. 2, 305-316. doi: 10.1016/S1097-2765(00)80275-0
99. Yi, R., Poy, M. N., Stoffel, M., and Fuchs, E. (2008). A skin microRNA promotes differentiation by repressing "stemness." Nature 452, 225-229. doi: 10.1038/nature06642
100. Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., and Oren, M. (1995). A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res. 23, 2584-2592. doi: 10.1093/nar/23.14.2584
101. Zhang, Z., and Zhang, R. (2005). p53-independent activities of MDM2 and their relevance to cancer therapy. Curr. Cancer Drug Targets. 5, 9-20. doi: 10.2174/1568009053332618